Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Herbal Medicine in the Treatment of Schizophrenia: A Review



Hajiaghaee R1 ; Akhondzadeh S2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
  2. 2. Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Psychiatric Research Center, Roozbeh Hospital, South Kargar Street, Tehran, 13337, Iran

Source: Journal of Medicinal Plants Published:2018

Abstract

As a chronic psychiatric disorder, schizophrenia affects the worldwide population with a lifetime prevalence of 1% and considerable long-term mortality, morbidity, and burden. Besides the adverse effects of routine treatment regimens, a significant portion of patients remain symptomatic despite treatment, especially those with negative symptoms which are the major disabling factors in these patients. There is an emerging role for herbal medicine in the treatment of schizophrenia. In this review we focus on some herbal medicines that have been reported to have some effects on schizophrenia. © 2018 Institute of Medicinal Plants. All Rights Reserved.
Related Docs
View other Related Docs
1. Microbiome and Schizophrenia, Avicenna Journal of Medical Biotechnology (2019)
2. Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production, Avicenna Journal of Medical Biotechnology (2021)
3. Integrating Psychiatry and Medical Biotechnology As a Way to Achieve Scientific, Precision, and Personalized Psychiatry, Avicenna Journal of Medical Biotechnology (2021)
4. Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia, Avicenna Journal of Medical Biotechnology (2018)
5. Simvastatin Adjunct Therapy for Negative Symptoms of Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial, International Clinical Psychopharmacology (2017)
6. The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era, Avicenna Journal of Medical Biotechnology (2021)
7. The Effects of Pioglitazone Adjuvant Therapy on Negative Symptoms of Patients With Chronic Schizophrenia: A Double-Blind and Placebo-Controlled Trial, Human Psychopharmacology (2016)
8. Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study, Pharmacopsychiatry (2016)
Experts (# of related papers)
View all Related Experts
Shahin Akhondzadeh Basti (12)
Somaye Arabzadeh (2)
Other Related Docs
9. The Role of Biotechnology in Latest Therapeutic Approaches for Diabetes Mellitus, Avicenna Journal of Medical Biotechnology (2024)
10. Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2024)
11. L-Carnosine As an Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, Psychiatry Research (2018)
12. Acetaminophen As Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Iranian Journal of Psychiatry (2018)